Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Candida Balanitis | Case report

Case report of an unusual hepatic abscess caused by Actinomyces odontolyticus in a patient with human immunodeficiency virus infection

Authors: Shao-Lun Hsu, Chin-Ting Wu, Yuan-Chen Chang, Chia-Kwung Fan, Yuarn-Jang Lee

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Actinomyces odontolyticus is not commonly recognized as a causative microbe of liver abscess. The detection and identification of A. odontolyticus in laboratories and its recognition as a pathogen in clinical settings can be challenging. However, in the past decades, knowledge on the clinical relevance of A. odontolyticus is gradually increasing. A. odontolyticus is the dominant oropharyngeal flora observed during infancy [Li et al. in Biomed Res Int 2018:3820215, 2018]. Herein we report a case of severe infection caused by A. odontolyticus in an immunocompromised patient with disruption of the gastrointestinal (GI) mucosa.

Case presentation

We present a unique case of a patient with human immunodeficiency virus infection who was admitted due to liver abscess and was subsequently diagnosed as having coinfection of A. odontolyticus, Streptococcus constellatus, and Candida albicans during the hospital course. The empirical antibiotics metronidazole and ceftriaxone were replaced with the intravenous administration of fluconazole and ampicillin. However, the patient’s condition deteriorated, and he died 3 weeks later.

Conclusion

This report is one of the first to highlight GI tract perforation and its clinical relevance with A. odontolyticus infection. A. odontolyticus infection should be diagnosed early in high-risk patients, and increased attention should be paid to commensal flora infection in immunocompromised individuals.
Literature
1.
go back to reference Li J, Li Y, Zhou Y, Wang C, Wu B, Wan J. Actinomyces and alimentary tract diseases: a review of its biological functions and pathology. Biomed Res Int. 2018;2018:3820215.PubMedPubMedCentral Li J, Li Y, Zhou Y, Wang C, Wu B, Wan J. Actinomyces and alimentary tract diseases: a review of its biological functions and pathology. Biomed Res Int. 2018;2018:3820215.PubMedPubMedCentral
2.
go back to reference Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev. 2015;28(2):419–42.CrossRef Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev. 2015;28(2):419–42.CrossRef
3.
go back to reference Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014;7:183–97.PubMedPubMedCentral Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014;7:183–97.PubMedPubMedCentral
4.
go back to reference Schaal KP, Lee HJ. Actinomycete infections in humans—a review. Gene. 1992;115(1–2):201–11.CrossRef Schaal KP, Lee HJ. Actinomycete infections in humans—a review. Gene. 1992;115(1–2):201–11.CrossRef
5.
go back to reference Sarkonen N, Könönen E, Summanen P, Kanervo A, Takala A, Jousimies-Somer H. Oral colonization with Actinomyces species in infants by 2 years of age. J Dent Res. 2000;79(3):864–7.CrossRef Sarkonen N, Könönen E, Summanen P, Kanervo A, Takala A, Jousimies-Somer H. Oral colonization with Actinomyces species in infants by 2 years of age. J Dent Res. 2000;79(3):864–7.CrossRef
6.
go back to reference Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu WH, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002–17.CrossRef Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu WH, et al. The human oral microbiome. J Bacteriol. 2010;192(19):5002–17.CrossRef
7.
go back to reference Považan A, Vukelic A, Secen N, Sazdanic-Velikic D, Bursac D. Actinomyces odontolyticus—associated bacteremia. Macedonian J Med Sci. 2012;5(3):324–7. Považan A, Vukelic A, Secen N, Sazdanic-Velikic D, Bursac D. Actinomyces odontolyticus—associated bacteremia. Macedonian J Med Sci. 2012;5(3):324–7.
8.
go back to reference Cone LA, Leung MM, Hirschberg J. Actinomyces odontolyticus bacteremia. Emerg Infect Dis. 2003;9(12):1629–32.CrossRef Cone LA, Leung MM, Hirschberg J. Actinomyces odontolyticus bacteremia. Emerg Infect Dis. 2003;9(12):1629–32.CrossRef
9.
go back to reference Lopes VN, Dantas MJ, Andrade P, Pinto-de-Sousa J. Secondary peritonitis by Actinomyces odontolyticus. Porto Biomed J. 2017;2(5):174–5.CrossRef Lopes VN, Dantas MJ, Andrade P, Pinto-de-Sousa J. Secondary peritonitis by Actinomyces odontolyticus. Porto Biomed J. 2017;2(5):174–5.CrossRef
10.
go back to reference Deivert DE, Potteiger CE, Komar M, Dubagunta S, Meschter S. Primary hepatic Actinomycosis: case report and literature review. Pract Gastroenterol. 2007;31(4):92–100. Deivert DE, Potteiger CE, Komar M, Dubagunta S, Meschter S. Primary hepatic Actinomycosis: case report and literature review. Pract Gastroenterol. 2007;31(4):92–100.
11.
go back to reference Adar R, Antebi E, David R, Mozes M. Abdominal actinomycosis. Israel J Med Sci. 1972;8(2):148–53.PubMed Adar R, Antebi E, David R, Mozes M. Abdominal actinomycosis. Israel J Med Sci. 1972;8(2):148–53.PubMed
12.
go back to reference Steininger C, Willinger B. Resistance patterns in clinical isolates of pathogenic Actinomyces species. J Antimicrob Chemother. 2016;71(2):422–7.CrossRef Steininger C, Willinger B. Resistance patterns in clinical isolates of pathogenic Actinomyces species. J Antimicrob Chemother. 2016;71(2):422–7.CrossRef
Metadata
Title
Case report of an unusual hepatic abscess caused by Actinomyces odontolyticus in a patient with human immunodeficiency virus infection
Authors
Shao-Lun Hsu
Chin-Ting Wu
Yuan-Chen Chang
Chia-Kwung Fan
Yuarn-Jang Lee
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06703-6

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.